Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
arcticnovartis
Fri, 03/27/2026 – 07:02
Read more about Novartis agrees to acquire Excellergy, Inc., building on allergy leadership…
